PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema
about
Translational Preclinical Research may Lead to Improved Medical Management of Non-Arteritic Anterior Ischemic Optic Neuropathy.Sustained neuroprotection from a single intravitreal injection of PGJ₂ in a nonhuman primate model of nonarteritic anterior ischemic optic neuropathy.Dendrimers Target the Ischemic Lesion in Rodent and Primate Models of Nonarteritic Anterior Ischemic Optic Neuropathy.SUR1-Associated Mechanisms Are Not Involved in Ischemic Optic Neuropathy 1 Day Post-Injury.The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rNAION).The arachidonic acid metabolite 11β-ProstaglandinF2α controls intestinal epithelial healing: deficiency in patients with Crohn's disease.Comparison of Neuroprotective Effect of Bevacizumab and Sildenafil following Induction of Stroke in a Mouse Model.Sustained neuroprotection from a single intravitreal injection of PGJ2 in a rodent model of anterior ischemic optic neuropathyOptic nerve inflammation and demyelination in a rodent model of nonarteritic anterior ischemic optic neuropathy.Ischemic optic neuropathies and their models: disease comparisons, model strengths and weaknesses.Acute arsenic treatment alters arachidonic acid and its associated metabolite levels in the brain of C57Bl/6 mice.Prostaglandin D2 synthase/GPR44: a signaling axis in PNS myelination.Oligodendrocyte death, neuroinflammation, and the effects of minocycline in a rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION).
P2860
Q33883506-4C5E0216-E1E2-4FEC-8EDC-33B6EB180F69Q35315071-495F43D3-0353-4805-85C3-D280CC2E1FA7Q36003140-BDFC2490-5A61-44E3-90B1-395288F1158CQ36112858-C322975C-FE39-41F3-BEBE-85CA1D574EF9Q36211702-BEFE6349-2361-4C01-B4F0-71CB921E5D00Q36860041-6D12F08F-FB1D-40ED-8A02-E8934687F102Q36995042-B057C12D-E7EA-4EB8-AAC8-06C45107D9F9Q37302311-4F80A8BB-56A9-4FBB-AA85-5697681BF303Q37372314-69D3F140-6E10-4749-A67C-525EC99869ADQ38359329-A9FA7F00-B380-4D6A-AA94-F21AE61CADCCQ42704683-57097D67-7652-4C02-AF72-5155D924A0A3Q48019092-E4641420-C5D4-4A8E-8CE7-4145D3E8F675Q49299699-B1D12964-3F2D-4FB3-AC07-C5F9BE3F4878
P2860
PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema
@ast
PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema
@en
PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema
@nl
type
label
PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema
@ast
PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema
@en
PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema
@nl
prefLabel
PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema
@ast
PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema
@en
PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema
@nl
P2093
P2860
P3181
P1433
P1476
PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema
@en
P2093
Adam C Puche
Bernard J Slater
Daniel Weinreich
James D Nicholson
Steven L Bernstein
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0050021
P407
P577
2012-01-01T00:00:00Z